Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Justyna Martyka"'
Autor:
Tomasz Rzymski, Aniela Gołas, Milena Mazan, Urszula Pakulska, Magdalena Masiejczyk, Agata Stachowicz, Justyna Martyka, Michał Combik, Katarzyna Wiklik, Kristina Goller, Marta Obacz, Elżbieta Adamczyk, Krzysztof Brzózka
Publikováno v:
Cancer Research. 82:P5-17
Breast cancer (BC) is a complex and heterogenous disease, and various approaches have been used to classify BC into several subtypes to improve diagnostic and therapeutic outcomes. One of the features of BC is deregulated transcription, which allows
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b404b7fe52742d451374cbdddce62185
https://doi.org/10.1158/1538-7445.sabcs21-p5-17-13
https://doi.org/10.1158/1538-7445.sabcs21-p5-17-13
Autor:
Andrzej Gondela, Marcin Leś, Maciej Mikulski, Łukasz Włoszczak, Frank Becker, Kamila Olech, Shivapriya Ramaswamy, Marcin Król, Henryk Pawlik, Christian Herhaus, Jose Alvarez, Joanna Szczęśniak, Heike Schilke, Paulina Niedziejko, Lindsey Crowley, Roberta Ferretti, Mireille Krier, Pamela Wahra, Pia Böpple, Timo Heinrich, Justyna Martyka, Ewa Sitek, Karol Zuchowicz, Ada Sala-Hojman, Anna Bartosik, Stefano Minguzzi, Łukasz Dudek, Frank Czauderna, Mateusz Nowak, Ansgar Wegener, Michal Galezowski, Carl Petersson, Sven Jäckel
Publikováno v:
Journal of medicinal chemistry. 64(16)
Due to increased lactate production during glucose metabolism, tumor cells heavily rely on efficient lactate transport to avoid intracellular lactate accumulation and acidification. Monocarboxylate transporter 4 (MCT4/SLC16A3) is a lactate transporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d3f6d43a88e3759b7bf441af1e7dd6
https://pubmed.ncbi.nlm.nih.gov/34382802
https://pubmed.ncbi.nlm.nih.gov/34382802
Autor:
Urszula Pakulska, Marta Obacz, Aniela Gołas, Milena Mazan, Magdalena Masiejczyk, Agata Stachowicz, Justyna Martyka, Michał Combik, Kinga Kęska, Katarzyna Wiklik, Kristina Goller, Elżbieta Adamczyk, Krzysztof Brzózka, Tomasz Rzymski
Publikováno v:
Cancer Research. 82:2647-2647
Breast cancer (BC) is a complex and heterogenous disease, and various approaches have been used to classify BC into several subtypes to improve diagnostic and therapeutic outcomes. One of the features of BC is deregulated transcription, which allows
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ea4730e36235b6564517d6dd348d4e0
https://doi.org/10.1158/1538-7445.am2022-2647
https://doi.org/10.1158/1538-7445.am2022-2647
Autor:
Agnieszka Łoboda, Aleksandra Grochowska, Agnieszka Sroka-Porada, Agnieszka Graczyk-Jarzynka, Patryk Górniak, Monika Prochorec-Sobieszek, Magdalena Cybulska, Malgorzata Firczuk, Przemyslaw Juszczynski, Bjoern Chapuy, Monika Noyszewska-Kania, Michal Kopczynski, Adam Ząbek, Tomasz Rzymski, Maciej Szydlowski, Piotr Młynarz, Radoslaw Zagozdzon, Anna Polak, Emilia Bialopiotrowicz, Michal Mikula, Ewa Jabłońska, Justyna Martyka, Neli Kachamakova-Trojanowska, Anna Szumera-Ciećkiewicz, Jozef Dulak, Krzysztof Brzózka, Piotr Kowalczyk, Karolina Pyziak
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 580 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 580 (2020)
Burkitt lymphoma (BL) is a rapidly growing tumor, characterized by high anabolic requirements. The MYC oncogene plays a central role in the pathogenesis of this malignancy, controlling genes involved in apoptosis, proliferation, and cellular metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee9fbfa5f77b179da0ac046e2c610e34
https://pubmed.ncbi.nlm.nih.gov/32138178
https://pubmed.ncbi.nlm.nih.gov/32138178
Autor:
Jose Alvarez, Agnieszka Dreas, Kamila Kozłowska, Kinga Michalik, Magdalena Zastawna, Anna Wrobel, Karol Zuchowicz, Andrzej Mazan, Peter Littlewood, Justyna Martyka, Magdalena Łośko, Tomasz Rzymski, Agnieszka Sroka-Porada, Paulina Niedziejko, Urszula Kulesza, Luigi Stasi, Joanna Szczęśniak, Krzysztof Brzózka, Adam Radzimierski, Katarzyna Wnuk-Lipinska, Katarzyna Wiklik, Anna Kowal
Publikováno v:
Cancer Research. 80:3656-3656
Background: Synthetic lethality is one of the most innovative approaches for selective targeting of cancer cells with defined genetic background. SMARCA2 and SMARCA4 are two mutually exclusive helicase/ATPase catalytic subunits belonging to SWI/SNF c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32d98c946ef82cd5a7565f22ed2e9d6a
https://doi.org/10.1158/1538-7445.am2020-3656
https://doi.org/10.1158/1538-7445.am2020-3656